Management for locally advanced cervical cancer : new trends and controversial issues
- 대한방사선종양학회
- 대한방사선종양학회지
- 제36권 제4호
-
2018.12254 - 264 (11 pages)
- 6

This article reviewed new trends and controversial issues, including the intensification of chemotherapy and recent brachytherapy (BT) advances, and also reviewed recent consensuses from different societies on the management of locally advanced cervical cancer (LACC). Intensive chemotherapy during and after radiation therapy (RT) was not recommended as a standard treatment due to severe toxicities reported by several studies. The use of positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) for pelvic RT planning has increased the clinical utilization of intensity-modulated radiation therapy (IMRT) for the evaluation of pelvic lymph node metastasis and pelvic bone marrow. Recent RT techniques for LACC patients mainly aim to minimize toxicities by sparing the normal bladder and rectum tissues and shortening the overall treatment time by administering a simultaneous integrated boost for metastatic pelvic lymph node in pelvic IMRT followed by MRI-based image guided adaptive BT.
Abstract
Introduction
Prognostic Factors Affecting Survival and Local Control in LACC
CCRT is Better Than RT Alone
Delivery of Chemotherapy to Enhance Treatment Results in LACC
Is Intensity-Modulated Radiation Therapy Essential?
BT is Mandatory unless There Are Technical Problems
Non-brachytherapy Boost for LACC
Review of Updated Cervical Cancer Management Guidelines
Aging and Management of Cervical Cancer
Conclusion
Conflict of Interest
References
(0)
(0)